Sio Gene surged last month after announcing positive six-month follow-up data from the low-dose cohort of the Phase 1/2 study evaluating its gene ...
https://www.google.com/url?rct=j&sa=t&url=https://seekingalpha.com/news/3654128-passage-bio-receives-citi-upgrade-on-recent-weakness&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNFutqu1O4FkuMT-tODZHX3bwqmPeQ
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.